We wish to inform you that the WHO Consultation on the Composition of Influenza Virus Vaccines for Use in the 2022 Southern Hemisphere Influenza Season will take place virtually from 13-23 September 2021, followed by an Information Meeting on the 24 September 2021, with vaccine manufacturers and national vaccine regulatory agencies. More information is available on the website here. The WHO recommendation will be based on the analysis of recent influenza viruses worldwide.

The COVID-19 pandemic has highlighted the need for innovative health technologies that can help countries improve health outcomes by providing shortcuts to solutions despite lack of infrastructure and resources. However, many of the new technologies that have come to market are unaffordable or unsuitable for low- and middle-income countries.

Alpha-lipoic acid is an antioxidant. Although there is some evidence it may help treat conditions related to diabetes, confirming studies are needed. Alpha lipoic acid (ALA) is an endogenous cofactor found in cells that can also be obtained in the diet. It is sometimes referred to as a “universal antioxidant” because it is both water- and fat-soluble and can neutralize reactive oxygen species (26). It is marketed as a dietary supplement for this reason, and is also used as adjuvant therapy for neuropathy and to improve glycemic control. Preclinical studies show that ALA plays a crucial role in energy production, and exerts antioxidant and apoptotic effects.